UNSPSC 51334103: Lurasidone

This classification denotes a serotonin antagonist and dopamine antagonist with the molecular formula C28H36N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 22IC88528T, chemically known as (3ar,4s,7r,7as)-2-((1r,2r)-2-(4-(1,2-benzothiazol-3-yl)piperazin-1-ylmethyl)cyclohexylmethyl)hexahydro-4,7-methano-2h-isoindole-1,3-dione but generally known as lurasidone, which bears US NIH Compound Identifier 213046.

UNSPSC 51334103 Lurasidone is a Commodity code that nominally describes a specific atypical antipsychotic medication; however, the recent state and local opportunity posted under this code shows a marked mismatch with the code's pharmaceutical scope. Seminole County, Florida's IFB60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, solicits 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for community health initiatives—neither of which aligns with lurasidone's psychiatric indication. The procurement requires quarterly deliveries to the Seminole County Community Health Building, with all shipping and delivery costs included in vendor proposals. Bidders must meet standard compliance requirements including drug-free workplace certification, E-Verify confirmation, and maintenance of workers' compensation, commercial general liability, and professional liability insurance. The contract carries an initial two-year term with a one-year renewal option and includes a three-month probationary period during which Seminole County may terminate without cause. The procurement is potentially funded through FEMA, introducing additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

The source supports no additional recent state and local opportunities under UNSPSC 51334103. The single Seminole County posting, while tagged to this code, represents a procurement of overdose-reversal and drug-deactivation products rather than the lurasidone medication the code nominally describes. This mismatch suggests either a tagging error in the county's e-Procurement Portal or a data inconsistency in the underlying opportunity record. Without corroborating opportunities aligned to the actual scope of lurasidone procurement, this code shows limited relevant recent activity in the state and local market as currently represented.